(2) Non-cardiac disease patients with increased hs-cTnT typically show mild elevations that overlap with those of NSTEMI patients, leading to a higher hs-cTnT cut-off for NSTEMI diagnosis, thus reducing its sensitivity. This evidence concerns the gene TNNT2 and heart disorder.